Insider Transactions Reported by 12 Insiders of Lexaria Bioscience Corp.

Symbol
LEXX, LEXXW on Nasdaq
Location
Kelowna, British Columbia, Canada

Insiders trading volume in the past year

Lexaria Bioscience Corp. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
CHRISTOPHER BUNKA Director $938,632 +$25,241 +2.8% 29 Jul 2025
/Richard Christopher/ Chief Executive Officer, Director $486,111 +$13,641 +2.9% 29 Jul 2025
/John Docherty/ President & CSO, Director $450,176 +$4,989 +1.1% 29 Jul 2025
/Michael Shankman/ Chief Financial Officer $122,000 15 May 2025
/William McKechnie/ Director $93,346 +$4,532 +5.1% 29 Jul 2025
/Vanessa Carle/ Secretary $92,182 +$683 +0.75% 29 Jul 2025
/Nicholas Baxter/ Director $90,280 15 May 2025
/Albert Reese Jr./ Director $65,778 15 May 2025
/Baljinder Bhullar/ Director $15,860 15 May 2025
/Catherine C. Turkel/ Director $9,703 12 Aug 2024
/Gregory Downey/ Chief Financial Officer $5,558 14 Oct 2022
/Nelson Cabatuan/ Chief Financial Officer 14 Mar 2024

Recent Insider Transactions by Companies or Individuals for Lexaria Bioscience Corp.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.